acetaminophen glutathione depletion mechanism View of Acetaminophen, the missing anion gap in the patient with metabolic acidosis GLYAT deficiency protects against acetaminophen-induced
Description
*Rossignol, D.A
Ewing, B
FGF-1 is currently under investigation in a clinical trial (NCT00117936) for patients with coronary heart disease
Furthermore, its protective effect in APAP-induced hepatotoxicity was linked to reduced mitochondrial dysfunction, oxygen consumption, and membrane potential (Granados-Castro et al., 2016)
